Skip to content

The Diversity of the Fungal and Bacterial in Colon Mucosa of Patients With Different Degree of Inflammation of Ulcerative Colitis

The Diversity of the Fungal and Bacterial in Colon Mucosa of Patients With Ulcerative Colitis Associated Different Clinical Classification

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03151850
Enrollment
50
Registered
2017-05-12
Start date
2016-07-31
Completion date
2017-08-31
Last updated
2017-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Keywords

fungal, mucosa, diversity, Basidiomycete

Brief summary

We analyzed the diversity of the fungal and bacterial within colon mucosa between patients with different degree of inflammation of Ulcerative Colitis.

Detailed description

In recent years, the relationship of intestinal fungus with inflammatory bowel disease was gradually revealed. We divided the patients with ulcerative colitis into three groups on the basis of World Gastroenterology Organisation (WGO) classification about inflammation degree and progress classification and established the healthy control group. Analyzing the diversity of the fungal and bacterial within colon mucosa between patients with different clinical classification, for example, the proportion of bacteria and fungi, the proportion of candida albicans, the proportion of yeasts, and so on.

Interventions

OTHERulcerative colitis

We take 2 pieces of biopsies in the sigmoid colon mucosa inflammation area during the colonoscopy and then perform gene sequencing.

OTHERControl

We take 2 pieces of biopsies in the sigmoid colon mucosa during the colonoscopy and then perform gene sequencing.

Sponsors

Qilu Hospital of Shandong University
CollaboratorOTHER
Xiuli Zuo
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients at our tertiary care medical center, aged between 18 and 80 years, scheduled to undergo surveillance colonoscopy. * The patients with ulcerative colitis for ulcerative colitis group. * The patients without ulcerative colitis for control group. * 18-80 years.

Exclusion criteria

* Using antibiotics, glucocorticoid and immunosuppressants wintin one month. * There are contraindications for enteroscopy and biopsy. * There are other intestinal diseases. * Pregnancy or breast-feeding women. * Patients with serious lung disease and mental illness.

Design outcomes

Primary

MeasureTime frameDescription
fungus detection rate6 monthsFungi detection rate was defined as the percentage of patients in whose colonic mucosa at least one kind of fungus were identified.
yeasts detection rate6 monthsYeasts detection rate was defined as the percentage of patients in whose colonic mucosa yeasts were identified.
candida albicans detection rate6 monthsCandida albicans detection rate was defined as the percentage of patients in whose colonic mucosa candida albicans were identified.

Countries

China

Contacts

Primary ContactXiuli Zuo, PhD
zuoxiuli@sina.com15588818685

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026